
Sign up to save your podcasts
Or


The startup, founded in 2024 by Daniel Moreira, Felix Steinbrenner and Samuel M., has built an AI platform that helps pharmaceutical companies launch new drugs worldwide.It streamlines pricing, market access and regulatory workflows for drug launches by automating data extraction and insight generation, enabling faster decision-making across global markets.The company saw RAPID growth after launching, reaching six figures in ARR within a few weeks. Today it's announced raising a $2.75 seed round led by Frontline Ventures, with participation from Y Combinator, Pace Ventures, Saras Capital and Springboard Health Angels.
By Sebastian JohnsonThe startup, founded in 2024 by Daniel Moreira, Felix Steinbrenner and Samuel M., has built an AI platform that helps pharmaceutical companies launch new drugs worldwide.It streamlines pricing, market access and regulatory workflows for drug launches by automating data extraction and insight generation, enabling faster decision-making across global markets.The company saw RAPID growth after launching, reaching six figures in ARR within a few weeks. Today it's announced raising a $2.75 seed round led by Frontline Ventures, with participation from Y Combinator, Pace Ventures, Saras Capital and Springboard Health Angels.